Anesthesia — Effect of Dexmedetomidine of Gastrointestinal Motility
Citation(s)
Aantaa R, Kanto J, Scheinin M, Kallio A, Scheinin H Dexmedetomidine, an alpha 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. Anesthesiology. 1990 Aug;73(2):230-5. doi: 10.1097/00000542-199008000-00007.
Ambartsumyan L, Rodriguez L, Morera C, Nurko S Longitudinal and radial characteristics of intra-anal pressures in children using 3D high-definition anorectal manometry: new observations. Am J Gastroenterol. 2013 Dec;108(12):1918-28. doi: 10.1038/ajg.2013.361. Epub 2013 Oct 29.
Anderson JL, Junkins E, Pribble C, Guenther E Capnography and depth of sedation during propofol sedation in children. Ann Emerg Med. 2007 Jan;49(1):9-13. doi: 10.1016/j.annemergmed.2006.06.011. Epub 2006 Aug 17.
Bassett KE, Anderson JL, Pribble CG, Guenther E Propofol for procedural sedation in children in the emergency department. Ann Emerg Med. 2003 Dec;42(6):773-82. doi: 10.1016/s0196-0644(03)00619-x.
Chandran V, Jagadisan B, Ganth B Validation of Adapted Dartmouth Operative Conditions Scale for sedation during pediatric esophagogastroduodenoscopy. Paediatr Anaesth. 2017 Jun;27(6):621-628. doi: 10.1111/pan.13127. Epub 2017 Apr 3.
Heard C, Burrows F, Johnson K, Joshi P, Houck J, Lerman J A comparison of dexmedetomidine-midazolam with propofol for maintenance of anesthesia in children undergoing magnetic resonance imaging. Anesth Analg. 2008 Dec;107(6):1832-9. doi: 10.1213/ane.0b013e31818874ee.
Kol IO, Egilmez H, Kaygusuz K, Gursoy S, Mimaroglu C Open-label, prospective, randomized comparison of propofol and sevoflurane for laryngeal mask anesthesia for magnetic resonance imaging in pediatric patients. Clin Ther. 2008 Jan;30(1):175-81. doi: 10.1016/j.clinthera.2008.01.008.
Koroglu A, Teksan H, Sagir O, Yucel A, Toprak HI, Ersoy OM A comparison of the sedative, hemodynamic, and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging. Anesth Analg. 2006 Jul;103(1):63-7, table of contents. doi: 10.1213/01.ANE.0000219592.82598.AA.
Ozkose Z, Demir FS, Pampal K, Yardim S Hemodynamic and anesthetic advantages of dexmedetomidine, an alpha 2-agonist, for surgery in prone position. Tohoku J Exp Med. 2006 Oct;210(2):153-60. doi: 10.1620/tjem.210.153.
Sen S, Chakraborty J, Santra S, Mukherjee P, Das B The effect of dexmedetomidine infusion on propofol requirement for maintenance of optimum depth of anaesthesia during elective spine surgery. Indian J Anaesth. 2013 Jul;57(4):358-63. doi: 10.4103/0019-5049.118558.
Effect of Dexmedetomidine of Gastrointestinal Motility
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
